Sfoglia per AUTORE
LO VULLO S
Collezione ASL Torino 5
Items : 2
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET). in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2021 Mar 30:clincanres.4928.2020. doi: 10.1158/1078-0432.CCR-20-4928.
2021
ASL Torino 5
ASL Torino 5
Vernieri C; Nichetti F; Lalli L; Moscetti L; Giorgi CA; Griguolo G; Marra A; Randon G; Rea CG; Ligorio F; Scagnoli S; De Angelis C; Molinelli C; Fabbri A; Ferraro E; Trapani D; Milani A; Agostinetto E; Bernocchi O; Catania G; Vantaggiato A; Palleschi M; Moretti A; Basile D; Cinausero M; Ajazi A; Castagnoli L; Lo Vullo S; Gerratana L; et alii...
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Jan;26(1):167-172. doi: 10.1093/annonc/mdu485. Epub 2014 Oct 24.
2015
ASL Torino 5
ASL Torino 5
Gianni AM; Pizzocaro G; Salvioni R; Carlo-Stella C; Siena S; Schiavetto I; Stagni S; Bengala C; Barone C; Biasoni D; Torelli T; Matteucci P; Catanzaro M; Magni M; Piva L; Farè E; Nicolai N; Raggi D; Giannatempo P; Lo Vullo S; Mariani L; Di Nicola M; Necchi A;